Premium
Inhibition of HIV‐1 Nef‐induced apoptosis of uninfected human blood cells by serine/threonine protein kinase inhibitors, fasudil hydrochloride and M3
Author(s) -
Okada Harue,
Takei Ryouichi,
Tashiro Masato
Publication year - 1998
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/s0014-5793(98)00045-3
Subject(s) - apoptosis , microbiology and biotechnology , signal transduction , kinase , protein kinase a , fas receptor , cytolysis , peripheral blood mononuclear cell , inhibitor of apoptosis domain , biology , chemistry , programmed cell death , cytotoxic t cell , biochemistry , in vitro , caspase
The Nef protein of HIV‐1 binds to and induces apoptotic cytolysis of uninfected but activated human peripheral blood mononuclear cells (PBMC) and various cell line cells derived from CD4 + T, CD8 + T and B lymphocytes, macrophages, and neutrophils. The Nef‐induced apoptosis also occurs with blood cells not expressing CD95 (Fas). The Nef‐induced apoptosis as well as Fas‐mediated apoptosis was inhibited by acetyl‐Try‐Val‐Ala‐Asp‐CHO, an IL‐1β converting enzyme (ICE) inhibitor. On the other hand, serine/threonine protein kinase (PK) inhibitors, H‐7, fasudil hydrochloride and M3, inhibited the Nef‐induced apoptosis, and not the Fas‐mediated one, without affecting the cell‐binding activity of Nef and Nef‐binding capacity of the activated cells. Preincubation of the cells with the drugs before being bound by Nef was required for the inhibition of apoptosis. These results suggest that the PK inhibitors specifically act on a cellular protein involved in the upper stream of signal transduction pathway of the Nef‐induced apoptosis, which is different from the Fas‐mediated pathway but meets it upstream of ICE. In addition, the drugs suppressed the cellular activation‐associated cell surface expression of a putative Nef‐binding protein in PBMC, although they had no influence on its expression in cell line cells. These findings suggest the feasibility of clinical use of the PK inhibitors to prevent the development of AIDS by inhibiting the Nef‐induced apoptosis of uninfected blood cells.